JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M111982200 on March 7, 2002

J. Biol. Chem., Vol. 277, Issue 20, 17706-17712, May 17, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/20/17706    most recent
M111982200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Lin, S.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Lin, S.-C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Casein Kinase I and Casein Kinase II Differentially Regulate Axin Function in Wnt and JNK Pathways*

Yi ZhangDagger, Wen-Jie Qiu§, Siu Chiu Chan, Jiahuai Han, Xi He||, and Sheng-Cai Lin**

From the Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China, the § Institute of Molecular and Cell Biology, Singapore 117609, Republic of Singapore, the  Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, and the || Division of Neuroscience, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115

Received for publication, December 16, 2001, and in revised form, March 4, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Axin uses different combinations of functional domains in down-regulation of the Wnt pathway and activation of the MEKK1/JNK pathway. We are interested in the elucidation of the functional switch of Axin. In the present study, we show that the Wnt activator CKIepsilon , but not CKIIalpha , Frat1, LRP5, or LRP6, inhibited Axin-mediated JNK activation. We also found that both CKIalpha and CKIepsilon interacted with Axin, whereas CKIIalpha did not bind to Axin and had no effect on Axin-mediated JNK activity even though CKIIalpha has also been suggested to be an activator for the Wnt pathway. The COOH-terminal region and the MEKK1-interacting domain of Axin are important for CKIalpha -Axin and CKIepsilon -Axin interaction. We further demonstrated that CKIepsilon and CKIalpha binding to Axin excluded MEKK1 binding, indicating that a competitive physical occupancy may underlie the inhibitory effect. Moreover, our data indicated that CKIepsilon kinase activity plays an additive role in this effect. Taken together, we have demonstrated that CKI and CKII exhibit differential effects on Axin-MEKK1 interaction and Axin-mediated JNK activation. Furthermore, our data suggest that CKI may provide a possible switch mechanism for Axin function in the regulation of Wnt and JNK pathways.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Since its initial cloning from the analysis of the Fused locus, in which mutations cause defects in axis formation (1), Axin has turned out to be a multidomain scaffold protein that manifests pleotropic functions in biological events including Wnt signaling, JNK mitogen-activated protein kinase signaling, and even tumorigenesis (2-8). Axin serves as an architectural protein on which many cellular factors have been identified including adenomatous polyposis coli (APC),1 beta -catenin, glycogen synthase kinase-3beta (GSK-3beta ), Dishevelled, protein phosphatase 2A (PP2A), and Axam (9-16). Factors frequently rearranged in activated T-cell (Frat1), as well as low-density lipoprotein receptor-related proteins LRP5 and LRP6 are also involved in transducing Wnt signaling (17-19). In the Wnt pathway, the Axin-based multimeric assembly acts to destabilize beta -catenin in unstimulated cells (20-22). In response to Wnt signals, Frat1 and Dishevelled somehow prevent GSK-3beta phosphorylation of beta -catenin, resulting in elevated cellular levels of beta -catenin (18, 23). Levels of beta -catenin and its regulated transcriptional activities are assumed to be the common denominators for Wnt signaling, and presumably cell growth (24-27). In addition, we have recently shown that ectopic expression of Axin-induced stress-activated protein kinase JNK activation, and also found that Axin interacts with MEKK1 specifically on a domain flanked by the regulator of G protein signaling domain and the GSK-3beta -binding site (5). The potential significance of the Axin-MEKK1 interaction is evident for the following reasons. First of all, Axin possesses a distinct binding domain for MEKK1, which we termed the MID domain. Second, MEKK1 binding per se does not suffice to activate JNK, as Axin also requires its C terminus for JNK activation. Furthermore, Axin activation of JNK is highly regulated by the Dishevelled protein (28), GSK-3beta binding (29), and homodimerization (5). More importantly, Axin could cause apoptosis in certain cells, which requires its JNK activating activity (30). While biological models are being created to address the biological functions of the Axin-mediated JNK activation, we are interested in the functional switch of Axin for its dual function in the MEKK1/JNK pathway and the Wnt signaling pathway.

Casein kinase Iepsilon (CKIepsilon ) is a serine/threonine kinase involved in the regulation of diverse cellular processes ranging from DNA replication and repair to circadian rhythm (31-33). CKIepsilon is regulated in part through inhibitory autophosphorylation at its carboxyl-terminal extensions (34, 35), and is maintained in active state by cellular protein phosphatases (36). Recently, through a functional cloning of factors that control axis formation in Xenopus, CKIepsilon was identified to be an activator for Wnt signaling. Overexpression of CKIepsilon mimics Wnt by stabilizing beta -catenin, thereby increasing expression of beta -catenin-dependent genes (37). Inhibition of endogenous CKIepsilon attenuated gene transcription stimulated by Wnt, indicating that the kinase activity of CKIepsilon is critical in transducing Wnt signal (37, 38). Based on a yeast two-hybrid screen, it was found to interact with Dishevelled (39), underscoring its biological significance in the Wnt pathway. Co-immunoprecipitation assays have confirmed that CKIepsilon is present in the Dishevelled·Axin complex (37, 39). CKIepsilon has also been shown to phosphorylate APC, in a manner that depends on Axin (40). One report also indicated that CKIalpha , another member of the CKI family, participates in transducing the Wnt signal (41). It has also been demonstrated that casein kinase II (CKII), which is involved in many proliferation-related processes in the cell, potentiates Wnt/beta -catenin signaling in mammary epithelial cells (42, 43).

The bifunctional nature of Axin suggested a switching mechanism might exist between the Wnt and JNK pathways. We previously found that GSK-3beta binding to Axin prevents Axin activation of JNK, and that its kinase activity is not required for this inhibiting effect, indicating that other factors may also participate the functional switch mechanism. In our continuous effort to elucidate the molecular mechanism responsible for Axin functional switch, we first tested if CKIepsilon could affect JNK activation by Axin. Surprisingly, CKIepsilon drastically attenuated the Axin/JNK signaling. In contrast, other Wnt signaling activators Frat1, LRP5, and LRP6 had no effect on Axin-mediated JNK activation. Moreover, we show that CKIalpha also exerts an inhibitory effect on Axin-mediated JNK activity. However, the casein kinase II family member CKIIalpha has no effect on Axin-mediated JNK activity although it also activates the Wnt pathway. We further demonstrated that the binding of CKIepsilon and CKIalpha to Axin excludes Axin-MEKK1 interaction in vivo, providing a possible direct mechanism for their inhibitory effect on the Axin-mediated JNK activation. Furthermore, we show that CKIepsilon kinase activity also contributes to this inhibitory effect, as a kinase-dead CKIepsilon K38R mutant partially lost its ability to inhibit the JNK activation and had reduced binding affinity for Axin. Thus, CKI may exert two antagonistic roles in Axin-based signaling pathways: one to prevent Axin-mediated destabilization of beta -catenin, and the other to inhibit Axin-induced JNK activation. These results provide a hypothetical switch mechanism for Axin dual function as regulated by CKI.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction of Plasmids-- Plasmids of mouse Axin, its deletion mutants, and FLAG-tagged JNK1, were described previously (5). LRP5 and LRP6 were previously constructed (19). CKIalpha was NH2-terminal tagged with HA through the NcoI site in pBluescript-HA vector and was transferred to pCMV5 vector through its EcoRI and XbaI sites. CKIIalpha and CKIIalpha KM were HA-tagged and transferred into the pCMV5 vector via its EcoRI and BamHI sites. CKIepsilon K38R was created by site-directed mutagensis using the QuikChangeTM site-directed mutagenesis kit (Stratagene); the oligonucleotide sequences used to create the CKIepsilon K38R mutant were 5'-GAAGTCGCCATCAGGCTGGAGTGTGTGAAG-3' and 5'-CACACACTCCAGCCTGATGGCGACTTCC-3'. CKIepsilon C1 was generated by removal of the SalI/XbaI region of full-length CKIepsilon , and these two sites were ligated to create a stop codon. CKIepsilon C2 was generated by ligation of the NH2-terminal NcoI/EcoRI fragment with the PCR-generated kinase domain region. The oligonucleotide sequences used for PCR were 5'-CTCTGCAAAGGCTATCCCTCCGAATTCTC-3' and 5'-TTCTAGAGCATGTTCCAGTCAAAGACG-3'. CKIepsilon C3 was generated by deletion of the EcoRI/XbaI fragment, followed by blunt-end reaction and re-ligation. Expression plasmid for HA-MEKK1 was a gift from Dr. M. Karin (University of California, San Diego). Frat1 was from Dr. A. Berns (The Netherlands Cancer Institute), and pGL3-fos-7LEF-luciferase was from Dr. L. T. William (Chiron Co.).

Transient Transfection and Immunokinase Assays-- Human embryonic kidney 293T cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 IU penicillin, 100 µg/ml streptomycin, and 2 mM glutamine. Transfections were performed in 60-mm dishes using SuperfectTM according to the manufacturer's instructions (Qiagen). The total amount of transfected DNA was adjusted to 4 µg with the empty vector pCMV5 where necessary. Cells were harvested at 40 h post-transfection and lysed in a lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM beta -glycerolphosphate, 1 mM sodium orthovanadate, 1 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). FLAG-tagged JNK1 was immunoprecipitated using mouse monoclonal anti-FLAG M2 beads (Sigma); the JNK activity was determined as described previously using 1 µg of GST-c-Jun-(1-79) (Stratagene) as substrate (5), followed by Western blotting using Phospho-c-Jun antibody (Cell Signaling) to examine the phosphorylation of c-Jun. Fold activation of the kinase was determined by an imaging analyzer (Molecular Dynamics model 425E) and normalized to their expression levels. Data are expressed as fold kinase activation compared with that in vector-transfected cells with the values representing the mean ± S.E. from three separate experiments.

Coimmunoprecipitation and Western Blot Analysis-- Transiently transfected 293T cells in 60-mm dishes were lysed in the same lysis buffer as described above. Cell lysates were sonicated three times for 5 s each, and centrifuged at 13,000 rpm for 30 min at 4 °C. Axin, CKIepsilon , CKIalpha , CKIIalpha , and MEKK1 proteins were immunoprecipitated from the cell lysates with anti-Myc (9E10), anti-HA (Roche Molecular Biochemicals), and anti-MEKK1 (C-22, Santa Cruz Biotechnology, Inc.) antibodies as indicated, and with protein A/G Plus-agarose beads (Santa Cruz Biotechnology, Inc.) in 4 °C for 3 h. Immunoprecipitates or total cell lysates were analyzed by Western blotting as previously described (5). The boiled samples were separated on 10% SDS-polyacrylamide gels and transferred to Immobilon-P membranes (Millipore). After blocking with 5% skim milk in PBS-T (PBS with 0.1% Tween 20) for 1 h, the membranes were probed with anti-Myc (9E10), anti-MEKK1 (C-22), anti-HA, or anti-FLAG antibodies. Bound antibodies were visualized by enhanced chemiluminescence using horseradish peroxidase-conjugated antibodies (Amersham Biosciences).

LEF1-luciferase Reporter Gene Assay-- 293T cells were transfected with 0.1 µg of pGL3-fos-7LEF-luciferase, 0.1 µg of pCMV-beta -galactosidase, and 0.2 µg of vector, CKIepsilon , or mutant CKIepsilon K38R, using DOSPER according to the manufacturer's instructions (Roche Molecular Biochemicals). Luciferase activities were measured as previously described (30). At 32 h post-transfection, cells were lysed and divided into two portions and measured for luciferase and beta -galactosidase activities (Promega). The ratio of luciferase activity to beta -galactosidase activity varied less than 10% among the samples. Data are presented as means from three separate experiments performed in triplicate.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

CKIe and CKIalpha , but Not CKIIalpha , Frat1, LRP5, or LRP6, Inhibited JNK Activation by Axin-- We previously made an interesting finding that Axin uses distinct combinations of functional domains in its role as a bifunctional protein in the Wnt signaling and MEKK1/JNK pathways (5). It was not clear how these two Axin-modulated pathways may be coordinated. As part of our efforts to address the switching mechanism, we tested whether the Wnt activators CKIepsilon , Frat1, LRP5, or LRP6 had any effect on Axin activation of JNK. We set out to address this question by expressing these Wnt signaling activators in 293T cells and monitoring the changes in Axin-mediated JNK activation using JNK immunokinase assay. As shown in Fig. 1, A and B, expression of Axin alone robustly activated JNK (~11-fold) as seen previously (5, 28, 29, 44). Expression of CKIepsilon , Frat1, LRP5, or LRP6 alone did not affect JNK activity in the immunokinase assay. Coexpression of Frat1, LRP5, or LRP6 with Axin had no effect on Axin-mediated JNK activation (Fig. 1B). However, coexpression of CKIepsilon with Axin significantly diminished the Axin-induced JNK activity (Fig. 1A). Interestingly, another member of the casein kinase I family, CKIalpha , also dramatically inhibited Axin-mediated JNK activation (Fig. 1A). In contrast, expression of the casein kinase II family member CKIIalpha , either wild type or its kinase-dead mutant CKIIalpha KM, had no effect on Axin-mediated JNK activation (Fig. 1A). Thus, Axin-mediated JNK activation is specifically inhibited by casein kinase I family members CKIepsilon and CKIalpha .


View larger version (39K):
[in this window]
[in a new window]
  		Fig. 1.   Axin activation of JNK is inhibited by CKIepsilon and CKIalpha , but not by CKIIalpha , Frat1, LRP5, or LRP6. A, CKIepsilon and CKIalpha , but not CKIIalpha , inhibits Axin activation of JNK. Cells were transfected with 1 µg of FLAG-JNK1, plus 1 µg of vector, HA-CKIepsilon , HA-CKIalpha , HA-CKITheta alpha , or HA-CKITheta alpha KM, in the presence (dark column) or absence (light column) of 1 µg of HA-Axin. Total cell lysates were probed with anti-HA for the expression of CKIepsilon , CKIalpha , CKIIalpha , and CKIIalpha KM. Following immunoprecipitation of FLAG-JNK1, their kinase activities were assayed using GST-c-Jun as substrate. The amount of the kinase in each immunoprecipitate was quantified by immunoblotting. Data are expressed as fold kinase activation compared with vector-transfected cells. The values represent the mean ± S.E. from three separate experiments. B, Frat1, LRP5, or LRP6 has no effect on Axin-mediated JNK activation. Cells were transfected with 1 µg of FLAG-JNK1, plus 1 µg of vector, Myc-Frat1, LRP5, or LRP6, in the presence (dark column) or absence (light column) of 1 µg of HA-Axin. Following immunoprecipitation of FLAG-JNK1, their kinase activities were assayed using GST-c-Jun as substrate. The amount of the kinase in each immunoprecipitate was quantified by immunoblotting. Data are expressed as described above.

CKIepsilon and CKIalpha , but Not CKIIalpha , Directly Bind to Axin and Exhibit a Competitive Binding with MEKK1 on Axin-- Previous studies had implied the presence of CKIepsilon and CKII in Axin-based complexes. Yeast two-hybrid screening and co-immunoprecipitation assays revealed that CKIepsilon and CKII can bind to Dishevelled (38). To elucidate the molecular mechanism by which CKIepsilon and CKIalpha blocked Axin-JNK activation, we first tested whether CKIepsilon and CKIalpha were physically associated with Axin. Immunoprecipitation assays using proteins tagged with different epitopes, coupled with Western blot analysis, revealed that Myc-Axin co-precipitated with CKIepsilon or CKIalpha (Figs. 2A and 3). This interaction was confirmed by in vitro binding assay using bacterially expressed CKI protein and in vitro TNT generated 35S-labeled Axin protein (data not shown). These data from the protein interaction assays are in agreement with a recent report (45). In contrast, CKIIalpha did not interact with Axin in the same immunoprecipitation assay (Fig. 2A).


View larger version (47K):
[in this window]
[in a new window]
  		Fig. 2.   Binding of CKIepsilon or CKIalpha to Axin excludes MEKK1 from Axin complex. A, CKIepsilon and CKIalpha , but not CKIIalpha , disrupts Axin-MEKK1 interaction. Cells were transfected with 1.5 µg of Myc-Axin, of 1.5 µg of vector, HA-CKIepsilon , HA-CKIalpha , or HA-CKIIalpha , in the absence or presence of 1.5 µg of MEKK1-C. Cell lysates were immunoprecipitated (IP) with anti-HA, anti-MEKK1, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting using anti-Myc for Axin. B, Frat1, LRP5, and LRP6 do not affect Axin-MEKK1 binding. Cells were transfected with 1.5 µg of HA-Axin, 1.5 µg of MEKK1-C, and 1.5 µg of vector, Frat1, LRP5, or LRP6. Cell lysates were immunoprecipitated (IP) with anti-HA, anti-MEKK1, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting using anti-HA for Axin.

We then included MEKK1 in the coimmunoprecipitation assays to determine whether the inhibitory effect on JNK activation observed with the casein kinase members was due to their interference with MEKK1 binding to Axin. When MEKK1 was included in these co-transfection and immunoprecipitation assays, Myc-Axin was only detected in MEKK1 immunoprecipitates from cells transfected with either the control vector or HA-CKIIalpha , which did not bind to Axin; but not from cells transfected with CKIepsilon or CKIalpha , which bound to Axin (Fig. 2A). These results suggest that CKIepsilon or CKIalpha binding to Axin exclude MEKK1 from binding to Axin. In contrast, co-expression of CKIIalpha , Frat1, LRP5, or LRP6 did not affect Axin-MEKK1 interaction (Fig. 2B).

CKIa and CKIepsilon do Not Affect Axin Homodimerization-- We have previously demonstrated that dimerization of Axin is required for its JNK activation. Specifically, Axin mutants that are still capable of binding to MEKK1 but lack of the dimerization domain failed to activate JNK. Intriguingly, MEKK1 also has to be present on both of the dimerized Axin proteins, as the Axin mutant AxinDelta MID, which retains the dimerization domain but lacks the MEKK1-binding domain, effectively inhibits Axin-induced JNK activation (5, 28). To further address the mechanism whereby CKI members inhibit Axin-induced JNK activation, we asked if binding of CKIepsilon or CKIalpha to Axin affects Axin homodimerization. HA- and Myc-tagged Axin proteins were coexpressed in the presence or absence of FLAG-tagged CKIepsilon , and lysates were immunoprecipitated with anti-HA or anti-Myc antibody. As shown in Fig. 3, HA-Axin was detected in anti-Myc immunoprecipitates, and vice versa. In the presence of FLAG-CKIepsilon , anti-FLAG antibody could precipitate both HA- and Myc-tagged Axin (Fig. 3). Moreover, HA-Axin can still be detected in anti-Myc immunoprecipitates, and Myc-Axin detected in anti-HA precipitates, indicating that Axin homodimerization is not affected by CKIepsilon (Fig. 3) or CKIalpha binding (data not shown).


View larger version (29K):
[in this window]
[in a new window]
  		Fig. 3.   CKIepsilon has no effect on Axin homodimerization. Cells were transfected with 1 µg of HA-Axin and Myc-Axin in the presence or absence of 1 µg of FLAG-CKIepsilon . Cell lysates were immunoprecipitated (IP) with anti-HA, anti-Myc, anti-FLAG, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA, anti-Myc, and anti-FLAG for Axin and CKIepsilon proteins, respectively.

The MID Domain of Axin Is Also Required for CKI-Axin Interaction-- The finding that CKIalpha and CKIepsilon directly interact with Axin prompted us to define the CKIepsilon - and CKIalpha -binding sites on Axin. The schematic diagrams in Fig. 4A depict the series of Myc-Axin mutant constructs used in co-transfection with HA-CKIepsilon or HA-CKIalpha . Cell lysates were immunoprecipitated with anti-Myc and anti-HA antibodies for Axin and CKI, respectively. As shown in Fig. 4, B and C, wild type Axin as well as the Axin deletion mutant N1 were detected in CKIalpha (Fig. 4B) and CKIepsilon (Fig. 4C) immunoprecipitates and vice versa, whereas the Axin mutant C1 lacking the COOH-terminal region was not co-precipitated with CKIalpha or CKIepsilon , indicating that the COOH-terminal region of Axin is crucial for interaction with CKIalpha and CKIepsilon . However, the COOH-terminal region alone (N3) is not sufficient for binding to either CKIalpha (Fig. 4B) or CKIepsilon (Fig. 4C). Interestingly, when the COOH-terminal of Axin was linked to the MID domain, this M3 Axin mutant restored the ability to interact both CKIalpha (Fig. 4B) and CKIepsilon (Fig. 4C). Although the M2 Axin mutant lacking the MID domain could still bind to CKIalpha (Fig. 4B), it showed significantly less affinity toward CKIepsilon (Fig. 4C). These data indicate that the binding of CKIepsilon to Axin obviously requires both the COOH-terminal sequence and the MID domain on Axin, whereas CKIalpha primarily depends on the COOH-terminal region of Axin for interaction. Since the Axin COOH-terminal alone does not suffice for CKI binding, the interaction between CKI and Axin may elicit conformational changes.


View larger version (58K):
[in this window]
[in a new window]
  		Fig. 4.   Mapping of CKIalpha - and CKIepsilon -binding sites on Axin. A, schematic diagrams depict different Axin deletion constructs used in the domain mapping experiments. B, mapping of CKIalpha -binding sites in Axin. Cells were transfected with 2 µg of HA-CKIalpha and 2 µg of Myc-tagged Axin, N1, M2, C1, N3, or M3. Cell lysates were immunoprecipitated (IP) with anti-HA, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-Myc for Axin and anti-HA for CKIalpha . C, mapping of the CKIepsilon -binding site in Axin. Cells were transfected with 2 µg of HA-CKIepsilon and 2 µg of Myc-tagged Axin, N1, M2, C1, N3, or M3. Cell lysates were immunoprecipitated with anti-HA, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-Myc for Axin and anti-HA for CKIepsilon .

Region of Amino Acids 248 to 295 in CKIepsilon Is Important for CKIepsilon -Axin Interaction-- Next we determined the structural requirements of CKIepsilon interaction with Axin. The schematic diagrams in Fig. 5A depict Myc-CKIepsilon constructs used in co-transfection with HA-Axin. Cell lysates were immunoprecipitated with anti-Myc and anti-HA for CKIepsilon and Axin, respectively. Results from the Western blots shown in Fig. 5B demonstrate that HA-Axin was detected in wild type Myc-CKIepsilon , deletion mutants Myc-CKIepsilon C1 and Myc-CKIepsilon C2 immunoprecipitates, but not in the deletion mutant Myc-CKIepsilon C3 immunoprecipitates, indicating that the region of amino acids 248 to 295 in the kinase domain of CKIepsilon is important for Axin-CKIepsilon interaction (Fig. 5B). Consequently, when MEKK1 was included in these co-transfection and co-immunoprecipitation assays, HA-Axin was only detected in MEKK1 immunoprecipitates from samples co-transfected with vector or Myc-CKIepsilon C3. MEKK1 immunoprecipitates from cells co-transfected with HA-Axin and wild type Myc-CKIepsilon , Myc-CKIepsilon C1, or Myc-CKIepsilon C2, however, did not contain Axin (Fig. 5C).


View larger version (39K):
[in this window]
[in a new window]
  		Fig. 5.   Mapping of CKIepsilon for CKIepsilon -Axin interaction. A, schematic diagrams depict different CKIepsilon deletion constructs used in the experiments. B, region of amino acids 248 to 295 in CKIepsilon is important for CKIepsilon -Axin interaction. Cells were transfected with 2 µg of HA-Axin and either of 2 µg of Myc-tagged CKIepsilon , CKIepsilon C1, CKIepsilon C2, or CKIepsilon C3. Cell lysates were immunoprecipitated (IP) with anti-HA, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA for Axin and anti-Myc for CKIepsilon . C, CKIepsilon C3 lost its ability to compete with MEKK1. Cells were transfected with 1.5 µg of HA-Axin, 1.5 µg of MEKK1-C, and 1.5 µg of vector, CKIepsilon , CKIepsilon C1, CKIepsilon C2, or CKIepsilon C3. Cell lysates were immunoprecipitated with anti-HA, anti-MEKK1, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting using anti-HA for Axin.

Effects of Kinase Activity of CKIepsilon on Axin-mediated JNK Activation-- Kinase activity of CKIepsilon is crucial for its role in Wnt signaling in that inhibition of endogenous CKIepsilon activity by the kinase-defective CKIepsilon K38R or a CKIepsilon antisense oligonucleotide attenuated gene transcription stimulated by Wnt-1 (37). We wondered if the kinase activity of CKIepsilon is also required for inhibiting Axin-mediated JNK activation. Kinase-defective mutant CKIepsilon K38R was generated, and coexpressed in the cells with FLAG-JNK1 and Axin. As shown in Fig. 6A, expression of Axin alone induced JNK activation by 11-fold as observed earlier (Fig. 1A). Expression of the wild type CKIepsilon alone did not alter the already low basal JNK activity. However, the kinase-defective mutant CKIepsilon K38R alone moderately enhanced basal JNK activity (Fig. 6A). This was confirmed in the experiments using the casein kinase I inhibitor CK7, N-2-aminoethyl5-chloroisoquinoline-8-sulfonamide (Seikagaku Corp., Japan). Treatment of cells with 160 µM of the inhibitor CK7 for 10 h led to more than 2-fold enhancement of basal JNK activation. Consistently, expression of CKIepsilon or CKIalpha in the presence of CK7 only partially attenuated Axin-mediated JNK activation (Fig. 6A). In contrast, expression of CKIIalpha had no effect on Axin-mediated JNK activation (Figs. 1A and 6A). These results suggest that the kinase activity of CKIepsilon also contributes to the regulation of JNK activation by Axin. CKIepsilon K38R bound to Axin on the same region as wild type CKIepsilon binding to Axin (Fig. 6B, and data not shown), and excluded MEKK1 from the Axin complex (Fig. 6C), suggesting physical binding is an a priori condition for the CKI inhibitory effect. However, the binding affinity of CKIepsilon K38R to Axin is less than that of wild type CKIepsilon to Axin. That may help to explain the partial loss of the inhibitory effect of CKIepsilon K38R on Axin-mediated JNK activation. This is also in agreement with the observation that the binding affinity of CKI to Axin is reduced upon treatment with casein kinase I inhibitor CK7 (data not shown). Compared with the partial requirement of the CKI kinase activity in the regulation of the Axin-JNK pathway, CKI kinase activity is fully required for the Wnt pathway (Fig 6D).


View larger version (33K):
[in this window]
[in a new window]
  		Fig. 6.   Effects of kinase activity of CKI on Axin-mediated JNK activation. A, kinase activity of CKI contributes to inhibitory effect of Axin-mediated JNK activity. Cells were transfected with 1 µg of FLAG-JNK1, plus 1 µg of vector, HA-CKIepsilon , HA-CKIepsilon K38R, HA-CKIalpha , or HA-CKITheta alpha , in the presence (dark column) or absence (light column) of 1 µg of HA-Axin with or without pretreatment of the cells with 160 µM CK-7 for 10 h before harvesting the cells as indicated. Immunokinase assays were performed and are presented as described in the legend to Fig. 1. The expression of CKIepsilon proteins was detected by immunoblotting anti-HA. B, kinase-defective CKIepsilon K38R is still capable of binding to Axin. Cells were transfected with 2 µg of HA-Axin and either of 2 µg of Myc-tagged CKIepsilon or CKIepsilon K38R. Cell lysates were immunoprecipitated (IP) with anti-HA, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA for Axin and anti-Myc for CKIepsilon . C, binding of kinase-defective CKIepsilon K38R to Axin also excludes MEKK1 from Axin. Cells were transfected with 1.5 µg of MEKK1-C and 1.5 µg of HA-Axin in the presence or absence of 1.5 µg of Myc-CKIepsilon K38R. Cell lysates were immunoprecipitated with anti-HA, anti-MEKK1, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting using anti-HA for Axin. D, kinase activity is necessary for CKIepsilon to stimulate LEF-luciferase activity. 293T cells were transfected with 0.1 µg of pGL3-fos-7LEF-luciferase, 0.1 µg of pCMV-beta -galactosidase, 0.2 µg of vector, Myc-CKIepsilon , or Myc-CKIepsilon K38R. The LEF1-luciferase activity is expressed as relative percentage luciferase activity compared with activity produced in cells transfected with vector in the absence of Axin, which is assigned a value of 1. The values represent the mean ± S.E. from three separate experiments performed in triplicate.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Biological signals are often transduced via multimeric complex formations of intracellular proteins, which are coordinated by architectural proteins referred to as scaffold proteins. Axin has become one of the most studied such scaffold proteins, and it is known to interact with many proteins including APC, MEKK1, beta -catenin, GSK-3beta , Dishevelled, PP2A, and Axam (5, 9-16). Most perplexing is that the same scaffold proteins can form different complexes in response to different signals. Our previous work has shown that Axin forms different complexes in its bifunctional roles. When GSK-3beta binds to its cognate site in Axin, MEKK1 cannot bind to the MID domain, although the two binding sites are physically separated. However, APC and beta -catenin are present in both of the complexes either for Wnt signaling or the Axin/MEKK1 pathway, suggesting the default function of Axin is to down-regulate the function of beta -catenin (29). As a continuous effort to understand how Axin exerts its diverse roles, we have extended our studies to other factors that participate in the Wnt pathway, and thoroughly analyzed how casein kinases may modulate Axin function in the Axin-regulated JNK pathway. In this study, we have demonstrated that CKI can inhibit Axin-mediated JNK activation, but that CKII, Frat1, LRP5, and LRP6 cannot, although they all activate Wnt-dependent transcription. These results indicate that the regulation of Axin activated JNK by CKI is not directly linked to Wnt signaling itself. This is particularly true given that the kinase activity of CKIepsilon is only partially involved in its inhibitory effect on the JNK pathway, whereas it is fully critical for transducing Wnt signaling.

It is interesting that CKIepsilon binds directly to both Dishevelled and Axin in the Dishevelled-Axin complex (37, 39, 45), whereas CKII binds to only Dishevelled (46). The importance of both CKI and CKII binding to Dishevelled in the Wnt signaling is demonstrated by the findings that both the CKIepsilon (39) and CKII (46) can phosphorylate and activate Dishevelled. CKIepsilon binding to Axin has been shown to be important for its phosphorylation of the APC protein (40). Our results in this study further suggest that the importance of the direct binding of CKI to Axin is to engage Axin functionality in the Wnt pathway. Although the specific triggers of CKI to either activate Wnt or regulate MEKK1/JNK pathway is at present unclear, it is evident that CKI binding to Axin is required for its inhibitory effect on Axin activation of JNK. More importantly, it excludes MEKK1 binding on Axin, which is a prerequisite for Axin-mediated JNK activation. Recent reports showed that CKI binds to the COOH-terminal Axin region overlapping with the PP2A binding area (44, 45). Our results here demonstrated that the COOH-terminal of Axin is required for its interaction with CKI, however, the COOH-terminal region alone does not suffice for CKI binding. These results indicate that binding of CKI to Axin may cause conformational changes in Axin, which may lead to the exclusion of MEKK1 binding to Axin. Indeed, our results here further demonstrated that the MID domain is also important for CKI binding, particularly for CKIepsilon . The observed lesser inhibitory effect by the kinase-dead mutant CKIepsilon K38R is mirrored by its diminished affinity for Axin, and is consistent with a requirement of its kinase domain for Axin binding. It is important to point out that the reduced binding affinity is not due to any protein structural change derived from the amino acid substitution, because experiments conducted with the casein kinase inhibitor CK7 also indicate that CKI kinase activity plays a role in the inhibition of Axin-mediated JNK activation.

The kinase activity of CKIepsilon is crucial in its role as an activator of the Wnt signaling pathway (37, 39). It was recently demonstrated that it activates the Wnt pathway, presumably by phosphorylating Dishevelled (38, 39). It has also been reported that the kinase activity of CKIepsilon is important for APC function (40). The kinase activity of CKIepsilon is also necessary in its function to regulate circadian rhythm, in that CKIepsilon controls the nuclear entry of the circadian regulator mPer1 by phosphorylation of mPer1 (32, 47). Our results in this study showed that the kinase activity of CKI also contributes to the inhibitory effect on Axin-mediated JNK activation; unlike GSK-3beta , in which the kinase activity of GSK-3beta is fully dispensable for its inhibitory effect on Axin-mediated JNK activation (29). Consistent with our results here, it is reported that inhibition of the kinase activity of CKI leads to JNK activation (44). As GSK-3beta plays a central role in transducing Wnt signaling, it is possible that CKI is not an initiating factor for Wnt signaling as in the case of Akt regulation of the Wnt pathway (48). This leads us to speculate that CKI may serve to fine tune Axin function in the balance between the two distinct pathways, Wnt and JNK.

The kinase activity of CKIepsilon can be regulated, and maintained in an active state, by cellular protein phosphatases such as PP2A (36). Given the fact that PP2A can bind to Axin through its catalytic domain (15) as well as bind to tumor suppressor APC through its B56 regulatory subunit (20), it is worth investigating the mutual regulation of PP2A and CKIepsilon activation in the Wnt signaling pathway. As CKIepsilon exhibits diverse functions, the specificity of the regulation of its kinase activities may require factors other than PP2A. Moreover, the present finding that the kinase activity of CKIepsilon also partially contributes to its inhibitory effect on the JNK pathway further highlights the diversity of the function and regulation of this important kinase.

In summary, we have demonstrated that CKI kinases bind directly to Axin and exclude Axin-MEKK1 interaction in vivo, thereby inhibiting Axin-mediated JNK activation. Moreover, our data have indicated that CKI kinase activity also contributed to this effect. Unlike CKI, CKII does not bind to Axin, and affects neither Axin-based molecular assemblies nor JNK activation. Thus, we have demonstrated that CKI and CKII exhibit differential effects on Axin-mediated JNK activation, and suggest that CKI may provide a possible switch mechanism for Axin function in the regulation of Wnt and JNK pathways.

    ACKNOWLEDGEMENTS

We thank Drs. A. Berns, M. Karin, and L. T. Williams for the various plasmids. We also thank Drs. John Hines, Brian Koh, and M. Zhang for critical reading of the manuscript.

    FOOTNOTES

* This work was supported in part by the Direct Allocation Fund, HKUST.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Present address: Dept. of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520.

** To whom correspondence should be addressed. Tel.: 852-23587294; Fax: 852-23581552; E-mail: linsc@ust.hk.

Published, JBC Papers in Press, March 7, 2002, DOI 10.1074/jbc.M111982200

    ABBREVIATIONS

The abbreviations used are: APC, adenomatous polyposis coli; CKIalpha , casein kinase Ialpha ; CKIepsilon , casein kinase Iepsilon ; CKIIalpha , casein kinase IIalpha ; Frat, frequently rearranged in activated T-cell; GSK-3beta , glycogen synthase kinase-3beta ; JNK/SAPK, c-Jun NH2-terminal kinase/stress-activated protein kinase; LRP, low-density lipoprotein receptor-related protein; MID, MEKK1-interacting domain; PP2A, protein phosphatase 2A; HA, hemagglutinin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T. J., Perry, W. L., III, Lee, J. J., Tilghman, S. M., Gumbiner, B. M., and Costantini, F. (1997) Cell 90, 181-192[CrossRef][Medline] [Order article via Infotrieve]
2. Cadigan, K. M., and Nusse, R. (1997) Genes Dev. 11, 3286-3305[Free Full Text]
3. Brown, J. D., and Moon, R. T. (1998) Curr. Opin. Cell Biol. 10, 182-187[CrossRef][Medline] [Order article via Infotrieve]
4. Wodarz, A., and Nusse, R. (1998) Annu. Rev. Cell Dev. Biol. 14, 59-88[CrossRef][Medline] [Order article via Infotrieve]
5. Zhang, Y., Neo, S. Y., Wang, X., Han, J., and Lin, S. C. (1999) J. Biol. Chem. 274, 35247-35254[Abstract/Free Full Text]
6. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., Yamaoka, Y., and Nakamura, Y. (2000) Nat. Genet. 24, 245-250[CrossRef][Medline] [Order article via Infotrieve]
7. Peifer, M., and Polakis, P. (2000) Science 287, 1606-1609[Abstract/Free Full Text]
8. Clevers, H. (2000) Nat. Genet. 24, 206-208[CrossRef][Medline] [Order article via Infotrieve]
9. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. (1998) EMBO J. 17, 1371-1384[CrossRef][Medline] [Order article via Infotrieve]
10. Fagotto, F., Jho, E.-h., Zeng, L., Kurth, T., Joos, T., Kaufmann, C., and Costantini, F. (1999) J. Cell Biol. 145, 741-756[Abstract/Free Full Text]
11. Spink, K. E., Polakis, P., and Weis, W. I. (2000) EMBO J. 19, 2270-2279[CrossRef][Medline] [Order article via Infotrieve]
12. Itoh, K., Krupnik, V. E., and Sokol, S. Y. (1998) Curr. Biol. 8, 591-594[CrossRef][Medline] [Order article via Infotrieve]
13. Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M., Sakamoto, I., Koyama, S., and Kikuchi, A. (1998) J. Biol. Chem. 273, 10823-10826[Abstract/Free Full Text]
14. Sakanaka, C., Weiss, J. B., and Williams, L. T. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 3020-3023[Abstract/Free Full Text]
15. Hsu, W., Zeng, L., and Costantini, F. (1999) J. Biol. Chem. 274, 3439-3445[Abstract/Free Full Text]
16. Kadoya, T., Kishida, S., Fukui, A., Hinoi, T., Michiue, T., Asashima, M., and Kikuchi, A. (2000) J. Biol. Chem. 275, 37030-37037[Abstract/Free Full Text]
17. Jonkers, J., Korswagen, H. C., Acton, D., Breuer, M., and Berns, A. (1997) EMBO J. 16, 441-450[CrossRef][Medline] [Order article via Infotrieve]
18. Farr, G. H., 3rd, Ferkey, D. M., Yost, C., Pierce, S. B., Weaver, C., and Kimelman, D. (2000) J. Cell Biol. 148, 691-702[Abstract/Free Full Text]
19. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J. P., and He, X. (2000) Nature 407, 530-535[CrossRef][Medline] [Order article via Infotrieve]
20. Seeling, J. M., Miller, J. R., Gil, R., Moon, R. T., White, R., and Virshup, D. M. (1999) Science 283, 2089-2091[Abstract/Free Full Text]
21. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., and Polakis, P. (1998) Curr. Biol. 8, 573-581[CrossRef][Medline] [Order article via Infotrieve]
22. Kishida, M., Koyama, S., Kishida, S., Matsubara, K., Nakashima, S., Higano, K., Takada, R., Takada, S., and Kikuchi, A. (1999) Oncogene 18, 979-985[CrossRef][Medline] [Order article via Infotrieve]
23. Kishida, S., Yamamoto, H., Hino, S., Ikeda, S., Kishida, M., and Kikuchi, A. (1999) Mol. Cell. Biol. 19, 4414-4422[Abstract/Free Full Text]
24. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. (1996) Cell 86, 391-399[CrossRef][Medline] [Order article via Infotrieve]
25. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Nature 382, 638-642[CrossRef][Medline] [Order article via Infotrieve]
26. He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. (1998) Science 281, 1509-1512[Abstract/Free Full Text]
27. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., and Ben-Ze'ev, A. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 5522-5527[Abstract/Free Full Text]
28. Zhang, Y., Neo, S. Y., Han, J., and Lin, S. C. (2000) J. Biol. Chem. 275, 25008-25014[Abstract/Free Full Text]
29. Zhang, Y., Qiu, W. J., Liu, D. X., Neo, S. Y., He, X., and Lin, S. C. (2001) J. Biol. Chem. 276, 32152-32159[Abstract/Free Full Text]
30. Neo, S. Y., Zhang, Y., Yaw, L. P., Li, P., and Lin, S. C. (2000) Biochem. Biophys. Res. Commun. 272, 144-150[CrossRef][Medline] [Order article via Infotrieve]
31. Fish, K. J., Cegielska, A., Getman, M. E., Landes, G. M., and Virshup, D. M. (1995) J. Biol. Chem. 270, 14875-14883[Abstract/Free Full Text]
32. Vielhaber, E., Eide, E., Rivers, A., Gao, Z. H., and Virshup, D. M. (2000) Mol. Cell. Biol. 20, 4888-4899[Abstract/Free Full Text]
33. Lowrey, P. L., Shimomura, K., Antoch, M. P., Yamazaki, S., Zemenides, P. D., Ralph, M. R., Menaker, M., and Takahashi, J. S. (2000) Science 288, 483-492[Abstract/Free Full Text]
34. Gietzen, K. F., and Virshup, D. M. (1999) J. Biol. Chem. 274, 32063-32070[Abstract/Free Full Text]
35. Rivers, A., Gietzen, K. F., Vielhaber, E., and Virshup, D. M. (1998) J. Biol. Chem. 273, 15980-15984[Abstract/Free Full Text]
36. Cegielska, A., Gietzen, K. F., Rivers, A., and Virshup, D. M. (1998) J. Biol. Chem. 273, 1357-1364[Abstract/Free Full Text]
37. Sakanaka, C., Leong, P., Xu, L., Harrison, S. D., and Williams, L. T. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12548-12552[Abstract/Free Full Text]
38. Sakanaka, C., Sun, T. Q., and Williams, L. T. (2000) Recent Prog. Horm. Res. 55, 225-236[Medline] [Order article via Infotrieve]
39. Peters, J. M., McKay, R. M., McKay, J. P., and Graff, J. M. (1999) Nature 401, 345-350[CrossRef][Medline] [Order article via Infotrieve]
40. Rubinfeld, B., Tice, D. A., and Polakis, P. (2001) J. Biol. Chem. 276, 39037-39045[Abstract/Free Full Text]
41. McKay, R. M., Peters, J. M., and Graff, J. M. (2001) Dev. Biol. 235, 388-396[CrossRef][Medline] [Order article via Infotrieve]
42. Song, D. H., Sussman, D. J., and Seldin, D. C. (2000) J. Biol. Chem. 275, 23790-23797[Abstract/Free Full Text]
43. Landesman-Bollag, E., Romieu-Mourez, R., Song, D. H., Sonenshein, G. E., Cardiff, R. D., and Seldin, D. C. (2001) Oncogene 20, 3247-3257[CrossRef][Medline] [Order article via Infotrieve]
44. McKay, R. M., Peters, J. M., and Graff, J. M. (2001) Dev. Biol. 235, 378-387[CrossRef][Medline] [Order article via Infotrieve]
45. Kishida, M., Hino, S.-i., Michiue, T., Yamamoto, H., Kishida, S., Fukui, A., Asashima, M., and Kikuchi, A. (2001) J. Biol. Chem. 276, 33147-33155[Abstract/Free Full Text]
46. Willert, K., Brink, M., Wodarz, A., Varmus, H., and Nusse, R. (1997) EMBO J. 16, 3089-3096[CrossRef][Medline] [Order article via Infotrieve]
47. Vielhaber, E., and Virshup, D. M. (2001) IUBMB Life 51, 73-78[CrossRef][Medline] [Order article via Infotrieve]
48. Fukumoto, S., Hsieh, C. M., Maemura, K., Layne, M. D., Yet, S. F., Lee, K. H., Matsui, T., Rosenzweig, A., Taylor, W. G., Rubin, J. S., Perrella, M. A., and Lee, M. E. (2001) J. Biol. Chem. 276, 17479-17483[Abstract/Free Full Text]

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
V. Bryja, G. Schulte, N. Rawal, A. Grahn, and E. Arenas
Wnt-5a induces Dishevelled pho